Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 10/20 | 0.51 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.50 |
| ▸ | HSD11B2 | P80365 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28223255 | 0.80 | CHRNA7 (0.49) | HSD11B1GAAEPHX2TSHRCHRNA7 | |
| SCHEMBL24609943 | 0.79 | DGAT1 (0.65) | DGAT1HSD11B1HSD11B2KDM4E | |
| SCHEMBL18007733 | 0.74 | HSD11B1 (0.49) | DGAT1HSD11B1HSD11B2KDM4EALDH1A1 | |
| Benzamide SCHEMBL28953881 | 0.72 | TSHR (0.55) | EPHX2KDM4EALDH1A1TSHRHTT | |
| SCHEMBL3644747 | 0.72 | HSD11B1 (0.43) | DGAT1HSD11B1HSD11B2KDM4EALDH1A1 | |
| SCHEMBL7154462 | 0.72 | LMNA (0.61) | GAAALDH1A1TSHRCHRNA7 | |
| SCHEMBL21768324 | 0.72 | LMNA (0.61) | GAAALDH1A1TSHRCHRNA7 | |
| SCHEMBL7154464 | 0.72 | LMNA (0.61) | GAAALDH1A1TSHRCHRNA7 | |
| SCHEMBL24106169 | 0.72 | HSD11B1 (0.40) | DGAT1HSD11B1HSD11B2 | |
| SCHEMBL12932438 | 0.72 | HSD11B1 (0.40) | DGAT1HSD11B1HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11181823-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11181823-B2 | Resist composition and patterning process | BICRA, HNRNPU, INSR | DGAT1 531/4885HSD11B1 3151/4885HSD11B2 2628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.